FDA Inspection
Baxter Healthcare CorporationFDA Inspection 1240745 - Baxter Healthcare Corporation - July 19, 2024
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on July 19, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 36223b91-ea94-4bfa-b2b3-d92b893771e9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240745
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Baxter Healthcare Corporation
12| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 3, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1149615 - 2021-07-30
- FDA Inspection 1075479 - 2018-12-21
- FDA Inspection 985599 - 2016-10-03
- FDA Inspection 925338 - 2015-05-01
- FDA Inspection 864714 - 2014-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.